Liu, Yi

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis.

Richeldi, L., Azuma, A., Cottin, V., Kreuter, M., Maher, T. M., Martinez, F. J., Oldham, J. M., Valenzuela, C., Clerisme-Beaty, E., Gordat, M., et al. (2025) · New England Journal of Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 297

Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation

Kuai, X.-Y., Yao, X.-H., Xu, L.-J., Zhou, Y.-Q., Zhang, L.-P., Liu, Y., Pei, S.-F., & Zhou, C.-L. (2021) · Microbial Cell Factories

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 179

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma

Li, X., Liu, Y., Granberg, K. J., Wang, Q., Moore, L. M., Ji, P., Gumin, J., Sulman, E. P., Calin, G. A., Haapasalo, H., et al. (2015) · Oncogene

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 99

MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma

Gao, Y., Liu, Y., Sun, L., Ouyang, X., Zhu, C., & Qin, X. (2021) · Genetic Testing and Molecular Biomarkers

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 9

Bioequivalence and safety study of letrozole tablet in healthy Chinese postmenopausal women volunteers

Liu, Y., & Zhou, D. (2013) · Journal of Chinese Pharmaceutical Sciences

Statistical Methods in Clinical TrialsMenopause: Health Impacts and Treatments

Cited by 2